Skip to main content

Unfortunately we don't fully support your browser. If you have the option to, please upgrade to a newer version or use Mozilla Firefox, Microsoft Edge, Google Chrome, or Safari 14 or newer. If you are unable to, and need support, please send us your feedback.

We'd appreciate your feedback.Tell us what you think! opens in new tab/window

Elsevier
Publish with us
AI-Generated response:

First line treatment for depression in the elderly

Answer generated on June 4, 2024

The AI-generated responses are for illustration purposes only and should not be used for medical purposes.

First-line treatment for depression in the elderly typically includes selective serotonin reuptake inhibitors (SSRIs) such as escitalopram, fluoxetine, or sertraline, but caution is advised due to potential side effects like hyponatremia and increased risk of falls.[1-3]

Psychotherapy is also recommended, especially cognitive behavioral therapy.[4]

  • SSRIs are preferred due to their tolerability and straightforward dosing, but they may cause hyponatremia, SIADH, and increase the risk of falls, particularly in those with a history of falls or fractures.[1-3]

  • Escitalopram should be limited to a maximum of 10 mg/day in adults aged 65 and older.[1]

  • Fluoxetine and sertraline have not shown significant differences in safety or efficacy between older and younger adults, but sensitivity in some older individuals cannot be ruled out.[2-3]

  • Psychotherapy, particularly cognitive behavioral therapy, is recommended as a first-line treatment and can be used alone or in combination with medications.[4]

  • Referral to a geriatric psychiatrist is advised for comprehensive evaluation and management.[4]

Additional info

When treating depression in the elderly, it is crucial to monitor for side effects closely due to the increased sensitivity of this population to medications. SSRIs, while generally safe, require careful consideration of potential risks such as hyponatremia and falls, which can be severe in older adults. Adjustments in other CNS-active medications might be necessary to minimize these risks. Regular follow-ups are essential to assess the effectiveness of the treatment and to make timely adjustments to the therapy plan. The combination of medication and psychotherapy often yields better outcomes, particularly in treatment-resistant cases. It is also important to consider the patient's overall medical condition and any comorbidities that might affect the choice of antidepressant therapy.

References

Reference 1

1.

Elsevier ClinicalKey Drug Monograph

Content last updated: May 4, 2024.

Contraindications And Precautions The selective serotonin reuptake inhibitors (SSRIs) are often a preferred antidepressant group for treatment of depression or other behavioral symptoms in the geriatric adult, including patients with dementia. In geriatric adults 65 years of age and older, lexapro dosages should be limited to 10 mg/day. Older adults are more likely to experience clinically significant hyponatremia with SSRI use. According to the Beers Criteria, SSRIs are considered potentially inappropriate medications (PIMs) in older adults with a history of falls or fractures; SSRIs can produce ataxia, impaired psychomotor function, syncope, and additional falls. If an SSRI must be used, consider reducing the use of other CNS-active medications and implement other strategies to reduce fall risk. Also, SSRIs may cause hyponatremia and SIADH; closely monitor sodium concentrations when initiating treatment or changing doses in older adults. The U.S. Omnibus Budget Reconciliation Act (OBRA) regulates the use of antidepressants in residents of long-term care facilities (LTCFs). When used to manage behavior, stabilize mood, or treat a psychiatric disorder, the facility should attempt to taper the antidepressant as outlined in the OBRA guidelines, unless a taper is clinically contraindicated. Dosages and durations of treatment used in the geriatric adult should be in accordance with prescribing labels, published literature recommendations, and expert guidelines.

Reference 2

2.

Elsevier ClinicalKey Drug Monograph

Content last updated: March 4, 2024.

Contraindications And Precautions The selective serotonin reuptake inhibitors (SSRIs) are often a preferred antidepressant group for treatment of depression or other behavioral symptoms in the geriatric adult, including patients with dementia. In clinical trials of sarafem, no overall differences in safety were observed between geriatric and younger adults, and other reported clinical experience has not identified differences in responses, but greater sensitivity of some older adults cannot be ruled out. Older adults are more likely to experience clinically significant hyponatremia with SSRI use. According to the Beers Criteria, SSRIs are considered potentially inappropriate medications (PIMs) in older adults with a history of falls or fractures; SSRIs can produce ataxia, impaired psychomotor function, syncope, and additional falls. If an SSRI must be used, consider reducing the use of other CNS-active medications and implement other strategies to reduce fall risk. Also, SSRIs may cause hyponatremia and SIADH; closely monitor sodium concentrations when initiating treatment or changing doses in older adults. The U.S. Omnibus Budget Reconciliation Act (OBRA) regulates the use of antidepressants in residents of long-term care facilities (LTCFs). When used to manage behavior, stabilize mood, or treat a psychiatric disorder, the facility should attempt to taper the antidepressant as outlined in the OBRA guidelines, unless a taper is clinically contraindicated. Dosages and durations of treatment used in the geriatric adult should be in accordance with prescribing labels, published literature recommendations, and expert guidelines.

Reference 3

3.

Elsevier ClinicalKey Drug Monograph

Content last updated: May 4, 2024.

Contraindications And Precautions The selective serotonin reuptake inhibitors (SSRIs) are often a preferred antidepressant group for treatment of depression or other behavioral symptoms in the geriatric adult, including patients with dementia. The pattern of zoloft solution-related adverse reactions was similar in clinical trials and reported clinical experience with geriatric and younger adults. However, greater sensitivity of some older individuals cannot be ruled out. SSRIs may cause hyponatremia and syndrome of inappropriate antidiuretic hormone secretion (SIADH), and geriatric adults appear to be at greater risk; closely monitor sodium concentrations when initiating treatment or changing doses in older adults. According to the Beers Criteria, SSRIs are considered potentially inappropriate medications (PIMs) in older adults with a history of falls or fractures; SSRIs can produce ataxia, impaired psychomotor function, syncope, and additional falls. If an SSRI must be used, consider reducing the use of other CNS-active medications and implement other strategies to reduce fall risk. The U.S. Omnibus Budget Reconciliation Act (OBRA) regulates the use of antidepressants in residents of long-term care facilities (LTCFs). When used to manage behavior, stabilize mood, or treat a psychiatric disorder, the facility should attempt to taper the antidepressant as outlined in the OBRA guidelines, unless a taper is clinically contraindicated. Dosages and durations of treatment used in the geriatric adult should be in accordance with prescribing labels, published literature recommendations, and expert guidelines.

Reference 4

4.

Elsevier ClinicalKey Clinical Overview

Treatment Depression Based on moderate-quality evidence, guidelines recommend cognitive behavioral therapy/psychotherapy as first line treatment of depression Selective serotonin reuptake inhibitors are recommended for severe depression or when nonpharmacologic treatments are unsuccessful Referral to a geriatric psychiatrist for evaluation and management is recommended Anxiety No specific guideline recommendations for treatment;

Follow up questions